Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Germany”

A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDGActive Not Recruiting
NCT06892288Phase 2, Phase 3Updated Aug 14, 2026
Sponsor: Glycomine, Inc.
Phosphomannomutase 2 Deficiency · PMM2-CDG
United States, Belgium, Czechia, France, Germany +5 more
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease DementiaRecruiting
NCT07284472Phase 2, Phase 3Updated Aug 14, 2026
Sponsor: Exciva GmbH
Agitation Associated With Alzheimer's Disease Dementia
United States, Canada, Czechia, Germany, Italy +4 more
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)Active Not Recruiting
NCT04736706Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Renal Cell
United States, Australia, Brazil, Canada, Chile +30 more
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With PolyneuropathyRecruiting
NCT07223203Phase 3Updated Aug 14, 2026
Sponsor: Alnylam Pharmaceuticals
Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy · hATTR-PN
United States, Australia, Brazil, Canada, Cyprus +12 more
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Recruiting
NCT06966700Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms · Triple Negative Breast Neoplasms · HR Low-Positive/HER2-Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +34 more
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)Active Not Recruiting
NCT01385176NAUpdated Aug 14, 2026
Sponsor: Boston Scientific Corporation
Heart Failure · Congestive Heart Failure
Belgium, Czechia, France, Germany, Italy +3 more
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.Recruiting
NCT06629779Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Metastatic Castration-Resistant Prostate Cancer
United States, Argentina, Brazil, Bulgaria, Canada +22 more
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged SeizuresRecruiting
NCT05077904Phase 3Updated Aug 14, 2026
Sponsor: UCB Biopharma SRL
Stereotypical Prolonged Seizures
United States, Australia, Bulgaria, China, Czechia +8 more
Single-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital Remote Monitoring Tool Configured for Patients With ATTR-CM: ACO-MonitorNot Yet Recruiting
NCT07557147N/AUpdated Aug 14, 2026
Sponsor: Bayer
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Austria, Germany, Italy
A Study of TAK-755 in Adults With Acute Ischemic StrokeRecruiting
NCT07392450Phase 2Updated Aug 14, 2026
Sponsor: Takeda
Acute Ischemic Stroke
United States, Belgium, Brazil, China, France +5 more
Advance Care Planning and Care Coordination for People With Parkinson's DiseaseCompleted
NCT05954013NAUpdated Aug 14, 2026
Sponsor: Radboud University Medical Center
Parkinson Disease · Parkinsonism
Austria, Estonia, Germany, Greece, Italy +2 more
Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study GroupActive Not Recruiting
NCT04230759Phase 2Updated Aug 14, 2026
Sponsor: Goethe University
Anal Cancer · Anal Carcinoma · Anal Cancer Stage III · Anal Cancer Stage II
Austria, Germany, Switzerland
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely ImmunocompromisedRecruiting
NCT07013474Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
COVID-19 Infection
United States, Argentina, Belgium, Brazil, Denmark +13 more
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)Recruiting
NCT06152575Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Multiple Myeloma
United States, Argentina, Australia, Belgium, Brazil +22 more
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple MyelomaRecruiting
NCT07555938Phase 3Updated Aug 14, 2026
Sponsor: Hoffmann-La Roche
Multiple Myeloma
United States, Canada, Germany, Greece, Israel +6 more
A Study to Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With Pancreatic Ductal AdenocarcinomaActive Not Recruiting
NCT05846516Phase 1Updated Aug 14, 2026
Sponsor: Boehringer Ingelheim
Pancreatic Ductal Adenocarcinoma
United States, Germany, Spain, Switzerland
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung CancerRecruiting
NCT07155174Phase 2Updated Aug 14, 2026
Sponsor: AbbVie
Small Cell Lung Cancer
United States, Belgium, China, Germany, Israel +8 more
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 DiabetesRecruiting
NCT07351045Phase 3Updated Aug 14, 2026
Sponsor: Hoffmann-La Roche
Obesity or Overweight
United States, Argentina, Australia, Belgium, Brazil +15 more
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.Recruiting
NCT06713837Phase 3Updated Aug 14, 2026
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Acute Myeloid Leukemia · Relapse/Recurrence
Czechia, Germany, Italy, Lithuania, Portugal +2 more
A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) MetastasesActive Not Recruiting
NCT04603807Phase 3Updated Aug 13, 2026
Sponsor: Hoffmann-La Roche
Carcinoma, Non-Small-Cell Lung
Brazil, China, Croatia, France, Germany +13 more
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker SystemRecruiting
NCT07118358NAUpdated Aug 13, 2026
Sponsor: Biotronik, Inc.
Leadless Pacemaker · Bradycardia · AV Block · Cardiac Rhythm Disorder
United States, Australia, Austria, Belgium, France +3 more
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, RespectivelyRecruiting
NCT07424404Phase 3Updated Aug 13, 2026
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Schizophrenia · Autism-Related Irritability
United States, Argentina, Australia, Canada, France +6 more
A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's DiseaseCompleted
NCT02782663Phase 2Updated Aug 13, 2026
Sponsor: AbbVie
Crohn's Disease (CD)
United States, Belgium, Canada, Czechia, Denmark +13 more
Registry Study on Prescription, Patient Pathways, Therapy Efficacy and Usage of Mandibular Advancement Devices in Obstructive Sleep Apnea - PATT-OSA RegistryActive Not Recruiting
NCT03924817N/AUpdated Aug 13, 2026
Sponsor: ResMed
Obstructive Sleep Apnea
Germany
A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' DiseaseCompleted
NCT05907668Phase 2Updated Aug 13, 2026
Sponsor: Immunovant Sciences GmbH
Graves Disease
Germany

Previous page Next page